Skip to main content
C

CELLUMED CO., LTD. — Investor Relations & Filings

Ticker · 049180 ISIN · KR7049180003 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2022-03-29 Board/Management Inform…
Country KR South Korea
Listing KO 049180

About CELLUMED CO., LTD.

http://www.clnzyme.co.kr/

CELLUMED CO., LTD. is a biotechnology company specializing in the development and manufacturing of medical devices, tissue grafts, and advanced biologics. The company operates as a human tissue bank, producing and supplying a variety of bone graft materials, including allografts and xenografts, for transplantation. Its medical device portfolio features orthopedic implants, with a key product being an artificial knee joint system. In the biologics sector, Cellumed develops growth factors and provides specialized enzymes, such as CLnZyme, which are utilized in the research, development, and production of RNA-based vaccines and therapeutics.

Recent filings

Filing Released Lang Actions
대표이사변경
Board/Management Information Classification · 1% confidence The document is a formal announcement regarding a change in the company's representative director (CEO). It details the previous and current leadership, the reason for the change (resignation), and the effective date. This falls directly under the category of board or management changes.
2022-03-29 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korea Exchange (KRX). It contains detailed financial tables including consolidated and separate financial statements, audit opinions, and capital information. While it reports on the audit, it is a standard regulatory disclosure of financial results and audit status rather than a standalone audit report document or an annual report (10-K). In the context of Korean regulatory filings (DART/KIND), this is classified as a regulatory filing regarding the submission of audit results. FY 2021
2022-03-21 Korean
사업보고서 (2021.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive 'Consolidated Audit Report' (연결감사보고서) for Cellumed Co., Ltd. for the fiscal year ending December 31, 2021. It includes the independent auditor's report, consolidated financial statements (statement of financial position, statement of comprehensive income, statement of changes in equity, statement of cash flows), and detailed notes. This document represents the formal audited financial results and is classified as an Audit Report (AR) as it is a standalone audit document rather than the full Annual Report (10-K) which typically includes management discussion and analysis, business overview, and other corporate disclosures. FY 2021
2022-03-21 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 1% confidence The document is a '주주총회소집공고' (Notice of Convocation of General Meeting of Shareholders) for Cellumed. It includes details about the meeting date, location, agenda items (such as financial statement approval, director appointments, and remuneration limits), and information regarding electronic voting. This document is a formal notice sent to shareholders to provide information and request their participation/votes for the upcoming Annual General Meeting. According to the provided definitions, this fits the 'Proxy Solicitation & Information Statement' (PSI) category, as it contains the necessary information and proxy materials for shareholders to exercise their voting rights.
2022-03-16 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and contains detailed information regarding the upcoming Annual General Meeting (AGM) of Cellumed, including voting procedures, electronic voting instructions, and the agenda. This document is a formal proxy solicitation material sent to shareholders to request their votes for the meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2022-03-16 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Cellumed. It outlines the meeting date, location, agenda items (including financial statement approval, director appointments, and remuneration limits), and procedures for electronic voting. This document is a standard proxy statement/notice sent to shareholders to inform them of an upcoming meeting and solicit their participation/votes, which fits the definition of a Proxy Solicitation & Information Statement.
2022-03-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.